Welcome to LookChem.com Sign In|Join Free

CAS

  • or

883554-87-8

N-(2-methylpropyl)piperidine-3-carboxamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

883554-87-8 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 883554-87-8 Structure

  • Basic information

    1. Product Name: N-(2-methylpropyl)piperidine-3-carboxamide
    2. Synonyms: N-(2-methylpropyl)piperidine-3-carboxamide;N-(2-METHYLPROPYL)-3-PIPERIDINECARBOXAMIDE;OTAVA-BB 1150174
    3. CAS NO:883554-87-8
    4. Molecular Formula: C10H20N2O
    5. Molecular Weight: 184.281
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 883554-87-8.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: N-(2-methylpropyl)piperidine-3-carboxamide(CAS DataBase Reference)
    10. NIST Chemistry Reference: N-(2-methylpropyl)piperidine-3-carboxamide(883554-87-8)
    11. EPA Substance Registry System: N-(2-methylpropyl)piperidine-3-carboxamide(883554-87-8)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 883554-87-8(Hazardous Substances Data)

883554-87-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 883554-87-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,3,5,5 and 4 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 883554-87:
(8*8)+(7*8)+(6*3)+(5*5)+(4*5)+(3*4)+(2*8)+(1*7)=218
218 % 10 = 8
So 883554-87-8 is a valid CAS Registry Number.

883554-87-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name N-Isobutyl-3-piperidinecarboxamide

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:883554-87-8 SDS

883554-87-8Upstream product

883554-87-8Downstream Products

883554-87-8Relevant articles and documents

SUBSTITUTED FUSED TRICYCLIC COMPOUNDS, COMPOSITIONS AND MEDICINAL APPLICATIONS THEREOF

-

Page/Page column 100; 102, (2012/10/08)

The present invention relates to substituted fused tricyclic compounds of formula (I) or (Ia), their tautomers, polymorphs, stereoisomers, prodrugs, solvates, co-crystals, pharmaceutically acceptable salts, pharmaceutical compositions containing them and methods of treating conditions and diseases that are mediated by JAK activity. The compounds of the present invention are useful in the treatment, prevention or suppression of diseases and disorders mediated by JAK activity. Such conditions include, but not limited to, arthritis, Alzheimer's disease, autoimmune thyroid disorders, cancer, diabetes, leukemia, T-cell prolymphocytic leukemia, lymphoma, myleoproliferation disorders, lupus, multiple myeloma, multiple sclerosis, osteoarthritis, sepsis, psoriatic arthritis, prostate cancer, T-cell autoimmune disease, inflammatory diseases, chronic and acute allograft transplant rejection, bone marrow transplant, stroke, asthma, chronic obstructive pulmonary disease, allergy, bronchitis, viral diseases, or Type I diabetes, complications from diabetes, rheumatoid arthritis, asthma, Crohn's disease, dry eye, uveitis, inflammatory bowel disease, organ transplant rejection, psoriasis and ulcerative colitis. The present disclosure also relates to process for the preparation of such compounds, and to pharmaceutical compositions containing them.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 883554-87-8